CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Michel Michaelides, MD, discusses study results from a gene therapy trial for RPGR-associated X-linked retinitis pigmentosa.
“We presented excellent safety and efficacy data both in terms of retinal sensitivity and, arguably more importantly, functional vision,” Michaelides said.